Kaj Blennow

Kaj Blennow

Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital

Affiliated withThe Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University HospitalSahlgrenska University HospitalSahlgrenska Academy at University of Gothenburg

+1

Research Area

Biography

Kaj Blennow has not added Biography.
If you are Kaj Blennow and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
Absolute Quantification of A&#946;<sub>1-42</sub> in CSF Using a Mass Spectrometric Reference Measurement Procedure
Publication title

Cited by 5

2017
2017

Other Publications

Article
Year
Evidence that the gene encoding insulin degrading enzyme influences human lifespan.

Human molecular genetics| PubMed ID: 18448515

2008
2009
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease.

Journal of Alzheimer's disease : JAD| PubMed ID: 19158416

2009
2009
2009
2009
2010
Amyloid beta and APP as biomarkers for Alzheimer's disease.

Experimental gerontology| PubMed ID: 19698775

2010
2010
2010
Subcortical vascular dementia biomarker pattern in mild cognitive impairment.

Dementia and geriatric cognitive disorders| PubMed ID: 19864909

2009
CSF biomarkers: pinpointing Alzheimer pathogenesis.

Annals of the New York Academy of Sciences| PubMed ID: 19906258

2009
2010
2010
2010
2010
2010
2010
2010
Biochemical markers in Alzheimer's disease clinical trials.

Biomarkers in medicine| PubMed ID: 20387305

2010
2010
2010
2010
2010
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.

International journal of Alzheimer's disease| PubMed ID: 20721354

2010
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.

International journal of Alzheimer's disease| PubMed ID: 20798852

2010
2010
2010
Biomarkers in Alzheimer's disease drug development.

Nature medicine| PubMed ID: 21052077

2010
2010
2011
Genetic association of sequence variants near AGER/NOTCH4 and dementia.

Journal of Alzheimer's disease : JAD| PubMed ID: 21297263

2011
Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

International journal of Alzheimer's disease| PubMed ID: 21487447

2010
Biomarker-based dissection of neurodegenerative diseases.

Progress in neurobiology| PubMed ID: 21524681

2011
2011
2011
Biomarkers for microglial activation in Alzheimer's disease.

International journal of Alzheimer's disease| PubMed ID: 22114747

2011
2012
2012
2012
Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?

Journal of Alzheimer's disease : JAD| PubMed ID: 22710917

2013
2012
2012
2012
2012
Fluid biomarkers in Alzheimer disease.

Cold Spring Harbor perspectives in medicine| PubMed ID: 22951438

2012
Serum levels of LIGHT in MS.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 23037546

2013
2012
2013
2013
2013
2013
2013
2014
CSF Presenilin-1 complexes are increased in Alzheimer's disease.

Acta neuropathologica communications| PubMed ID: 24252417

2013
2013
2014
2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 24721526

2014
2014
2015
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 24795085

2015
2014
2014
2014
2014
2014
Agitation in dementia: relation to core cerebrospinal fluid biomarker levels.

Dementia and geriatric cognitive disorders extra| PubMed ID: 25298777

2014
2015
2015
2015
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 25533203

2015
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 25804998

2015
Amyloid biomarkers in Alzheimer's disease.

Trends in pharmacological sciences| PubMed ID: 25840462

2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2016
2016
2015
2015
2015
2016
2017
2016
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.

Medicine and science in sports and exercise| PubMed ID: 26765633

2016
2016
2016
2016
2016
2016
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.

Movement disorders : official journal of the Movement Disorder Society| PubMed ID: 27145480

2016
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.

Clinica chimica acta; international journal of clinical chemistry| PubMed ID: 27216941

2016
2016
2016
2016
2016
2016
Specific Triazine Herbicides Induce Amyloid-β42 Production.

Journal of Alzheimer's disease : JAD| PubMed ID: 27589520

2016
2016
2016
2016
2016
2016
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.

Journal of Alzheimer's disease : JAD| PubMed ID: 27662296

2016
2017
Plasma tau in Alzheimer disease.

Neurology| PubMed ID: 27694257

2016
2016
2017
2017
2016
2017
Traumatic brain injuries.

Nature reviews. Disease primers| PubMed ID: 27853132

2016
2017
2017
2016
2016
2017
2016
2017
2017
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.

Journal of Alzheimer's disease : JAD| PubMed ID: 28059797

2017
2017
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 28073031

2017
2017
2017
2017
2017
2017
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 28216393

2017
2017
2017
2017
2017
The immune response of the human brain to abdominal surgery.

Annals of neurology| PubMed ID: 28253549

2017
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association| PubMed ID: 28263742

2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.

Journal of neural transmission (Vienna, Austria : 1996)| PubMed ID: 28656371

2017
2017
2017
2017
2017
2017
Serum tau and neurological outcome in cardiac arrest.

Annals of neurology| PubMed ID: 28981963

2017
2017
2017
2017
2017
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study.

American journal of respiratory and critical care medicine| PubMed ID: 29125327

2017
2017